Article Details
Retrieved on: 2024-05-24 15:25:14
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article details a collaboration between Degron Therapeutics and Takeda, focusing on developing molecular glue degraders for oncology, neuroscience, and inflammation. This aligns with the key concept of neuroscience and the tags, showcasing innovations in drug discovery and medicinal chemistry.
Article found on: www.pharmexec.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here